Anjana Munshi - Genetic Mutations

Author Information

Anjana Munshi is a distinguished researcher affiliated with the Department of Human Genetics and Molecular Medicine at the Central University of Punjab, Bathinda, India. With an extensive background in genetics, her work encompasses various aspects of human health and disease, particularly focusing on molecular mechanisms and therapeutic interventions.

Research Contributions

Anjana Munshi has made significant contributions to the field of genetics and molecular medicine through her extensive research on topics such as cancer metastasis, diabetic neuropathy, epigenetic instability, and the role of non-coding RNAs in various diseases. Her recent work includes studies on miRNA signatures in diabetic retinopathy and nephropathy, the impact of oxidative stress on tumorigenesis, and the mechanisms of viral entry in the brain related to COVID-19 induced ischemic strokes. Her research not only enhances our understanding of these complex biological processes but also opens pathways for potential therapeutic interventions.

Aliases

Anjana Munshi is also known by the following aliases: A Munshi, A. M. Munshi, and A. Munshi.

Publication and Citation Metrics

Metric	Value
Total Citation Count	2835
H-Index	29
Total Paper Count	200

Publications:

Long non-coding RNAs involved in different steps of cancer metastasis

DOI: 10.1007/s12094-021-02761-z

Year: 2022

Targeting Redox Homeostasis of Tumor Cells by Therapeutic Compounds in Cancer

DOI: 10.1007/978-981-16-1247-3_271-1

Year: 2022

Role of miRNAs in diabetic neuropathy: mechanisms and possible interventions.

DOI: 10.1007/s12035-021-02662-w

Year: 2022

miRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms.

DOI: 10.1007/s13105-021-00867-0

Year: 2022

Epigenetic Instability Caused by Oxidative Stress Triggers Tumorigenesis

DOI: 10.1007/978-981-15-9411-3_184

Year: 2022

Common microRNAs in epilepsy and migraine: their possibility as candidates for biomarkers and therapeutic targets during comorbid onset of both conditions.

DOI: 10.2174/1871527321666220426103253

Year: 2022

COVID-19 induced ischemic stroke and mechanisms of viral entry in brain and clot formation: a systematic review and current update.

DOI: 10.1080/00207454.2022.2056460

Year: 2022

Role of lncRNAs in the Development of Ischemic Stroke and Their Therapeutic Potential.

DOI: 10.1007/s12035-021-02359-0

Year: 2021

Human Blood Group Systems and Haemoglobinopathies

DOI: 10.5772/INTECHOPEN.82992

Year: 2021

Design, Synthesis and Biological Evaluation of New 5‐(2‐Nitrophenyl)‐1‐aryl‐1 H ‐pyrazoles as Topoisomerase Inhibitors

DOI: 10.1002/SLCT.202101459

Year: 2021

What are the Latest Diagnostic Tools?

What are Induced Mutations?

How Are Synonymous Mutations Detected?

How Do CFTR Gene Mutations Cause Disease?

How do ZFNs function?

What is a Substitution Mutation?

How Do Genes Work?

How is the Regulatory Framework for Genetic Mutations in Agriculture?

What Types of Prenatal Tests Are Available?

What Role Do Genetic Mutations Play in Prenatal Screening?

Partnered Content Networks

Relevant Topics